First Trust NYSE Arca Biotechnology Index Fund company info

What does First Trust NYSE Arca Biotechnology Index Fund do?
First Trust NYSE Arca Biotechnology Index Fund (NYSE:FBT) is a specialized investment vehicle that channels funds into a broad array of biotechnology firms. This fund mirrors the performance of the NYSE Arca Biotechnology Index, thereby giving investors exposure to companies involved in the research, development, and distribution of biotechnological products and services. Through investing in a diverse portfolio of biotech firms, FBT aims to offer growth opportunities by capitalizing on advancements in the biotech sector and increasing demand for medical innovations. The objective of this fund is to generate returns that closely match the price and yield performance of the biotechnology index, making it an attractive option for those looking to invest in the rapidly evolving biotech industry.
First Trust NYSE Arca Biotechnology Index Fund company media
Company Snapshot

Is First Trust NYSE Arca Biotechnology Index Fund a public or private company?

key
Ownership
Public

How many people does First Trust NYSE Arca Biotechnology Index Fund employ?

people
Employees
1,072

What sector is First Trust NYSE Arca Biotechnology Index Fund in?

pie chart
Sector
ETF

Where is the head office for First Trust NYSE Arca Biotechnology Index Fund?

location pin
Head Office
Wheaton, United States

What year was First Trust NYSE Arca Biotechnology Index Fund founded?

founded flag
Year Founded
2006
What does First Trust NYSE Arca Biotechnology Index Fund specialise in?
/Biotechnology Investments /ETF Products /Passive Management /Benchmark Tracking /Risk Diversification /Capital Appreciation

What are the products and/or services of First Trust NYSE Arca Biotechnology Index Fund?

Overview of First Trust NYSE Arca Biotechnology Index Fund offerings
Investment Objective: Seeks to replicate, before fees and expenses, the price and yield of the NYSE® Arca® Biotechnology Index. This index measures the performance of companies within the biotechnology industry.
Exposure to Biotechnology Companies: By investing in FBT, you gain exposure to a variety of companies involved in the research, development, and commercialization of biological products and technologies.
Passive Management: The ETF is passively managed, meaning it replicates the holdings of the underlying index and doesn't try to outperform it through security selection. The index provider determines the weighting of each company in the index.
Diversification: FBT holds shares in a basket of biotechnology companies, offering some level of diversification within this sector of the healthcare industry.
Potential Returns: The value of FBT's shares will fluctuate based on the performance of the underlying companies in the NYSE® Arca® Biotechnology Index. Investors can potentially benefit from overall growth in the biotechnology sector.
Liquidity: FBT trades on a stock exchange like any other stock, providing investors with liquidity to buy or sell shares throughout the trading day.